母体血浆DNA全基因组启动子谱无创预测胎儿生长受限
本研究为嵌套病例对照研究,纳入810例妊娠(162例FGR病例和648例对照),基于母体血浆cfDNA核小体谱分析启动子区域差异覆盖基因,用SVM和LR模型构建分类器。基于14个差异启动子覆盖基因的SVM分类器CFGR 1表现最佳,AUC为0.803(95%CI 0.767-0.839),准确率83.2%。
要点
- 基于母体血浆cfDNA核小体谱的启动子覆盖差异可无创预测FGR风险。
- SVM分类器CFGR 1基于14个基因,AUC 0.803,准确率83.2%。
- 该方法有望在早期妊娠阶段评估FGR风险。
核心结论
- 基于母体血浆cfDNA核小体谱成功开发了一种有前景的FGR预测方法,可在早期妊娠阶段评估FGR风险。
研究设计与样本
- 嵌套病例对照研究,纳入810例妊娠,其中162例FGR病例和648例对照。
- 基于母体血浆cfDNA核小体谱识别启动子核小体足迹差异,使用SVM和LR模型构建分类器。
主要发现
- 通过低覆盖度全基因组测序数据分析,识别出FGR病例与对照在启动子区域(转录起始位点-1000至+1000 bp)DNA覆盖度显著差异的基因。
- 基于14个差异启动子覆盖基因的SVM分类器CFGR 1分类性能最高,AUC为0.803(95%CI 0.767-0.839),准确率83.2%。
临床怎么用
- 该无创预测方法有望用于早期妊娠阶段FGR风险评估,但需进一步验证后方可临床推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To predict fetal growth restriction (FGR) by whole-genome promoter profiling of maternal plasma. DESIGN: Nested case-control study. SETTING: Hospital-based. POPULATION OR SAMPLE: 810 pregnancies: 162 FGR cases and 648 controls. METHODS: We identified gene promoters with a nucleosome footprint that differed between FGR cases and controls based on maternal plasma cell-free DNA (cfDNA) nucleosome profiling. Optimal classifiers were developed using support vector machine (SVM) and logistic regression (LR) models. MAIN OUTCOME MEASURES: Genes with differential coverages in promoter regions through the low-coverage whole-genome sequencing data analysis among FGR cases and controls. Receiver operating characteristic (ROC) analysis (area under the curve [AUC], accuracy, sensitivity and specificity) was used to evaluate the performance of classifiers. RESULTS: Through the low-coverage whole-genome sequencing data analysis of FGR cases and controls, genes with significantly differential DNA coverage at promoter regions (-1000 to +1000 bp of transcription start sites) were identified. The non-invasive 'FGR classifier 1' (CFGR 1) had the highest classification performance (AUC, 0.803; 95% CI 0.767-0.839; accuracy, 83.2%) was developed based on 14 genes with differential promoter coverage using a support vector machine. CONCLUSIONS: A promising FGR prediction method was successfully developed for assessing the risk of FGR at an early gestational age based on maternal plasma cfDNA nucleosome profiling. TWEETABLE ABSTRACT: A promising FGR prediction method was successfully developed, based on maternal plasma cfDNA nucleosome profiling.
引用
- Xu C, Guo Z, Zhang J, et al. Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study. BJOG. 2020. PMID: 32364311. doi:10.1111/1471-0528.16292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。